In vitro susceptibilities of 98 isolates of Brucella melitensis to N-formimidoyl thienamycin, tetracycline, co-trimoxazole, rifampin, and cefoxitin were determined. N-Formimidoyl thienamycin showed good activity which was similar to those of tetracycline and rifampin and different from that of the other beta-lactam antibiotic tested (cefoxitin), which showed poor activity. Co-trimoxazole showed good activity.
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N-Formimidoyl thienamycin (N-F-thienamycin) is a novel beta-lactam antibiotic which has been shown to be highly effective against a broad spectrum of microorganisms (8, 10, 11) . The purpose of this study was to determine the activity of this new agent against Brucella melitensis in comparison with those of three other drugs known to be active against this organism (rifampin, co-trimoxazole, and tetracycline) and with that of another beta-lactam antibiotic (cefoxitin).
N-F-thienamycin, cefoxitin, tetracycline chlorhydrate, rifampin, and trimethoprim-sulfamethoxazole (co-trimoxazole) were (5) with a Steers replicator (9). Iso-Sensitest Agar CM47L (Oxoid Ltd.) was the medium used. Incubation was carried out at 370C for 48 h. The concentrations used ranged from 16 to 0.06 ,ug/ml for N-Fthienamycin, tetracycline, and rifampin; from 128 to 2 ,ug/ml for cefoxitin; and from 200 to 0.19 ,ug/ml for co-trimoxazole. In the co-trimoxazole preparation, the ratio of trimethoprim to sulfamethoxazole was 1:20. The minimal inhibitory concentration (MIC) was defined as the lowest concentration which either prevented any growth or which allowed the growth of a maximum of 3 to 4 isolated colonies (5). The experiment was controlled by using strains of B. melitensis 16M (Central Veterinary Laboratory, Weybridge, Surrey, England), which are inhibited by the following MICs: N-F-thienamycin, 0.5 ,g/ml; tetracycline, 0.25 ,ug/ml; rifampin, 0.5 pLg/ ml; cefoxitin, 32 pg/ml; and co-trimoxazole, 1.56 ,g/ml. Also used as a control organism was Staphylococcus aureus ATCC 25923, which is inhibited by the following MICs: N-F-thienamycin, <0.06 ,ug/ml; tetracycline, 50.5 pg/ml; rifampin, 0.06 ,g/ml; cefoxitin, _2 ,g/ml; and co-trimoxazole, <1.56 &g/ml. Both organisms were included in each determination for reproducibility. Figure 1 shows the cumulative percentages of strains inhibited by tetracycline, rifampin, N-Fthienamycin, cefoxitin, and co-trimoxazole. The first three agents exhibited good in vitro activity and gave very similar results. Inhibition of all strains was achieved by tetracycline at 0.5 ,g/ml or less, by rifampin at 1 ,ug/ml or less, and by N-F-thienamycin at 2 ,g/ml or less. On the other hand, cefoxitin showed poor activity, inhibiting only 15.3% of all strains at a concentration of 16 iiLg/ml or less; total inhibition required a concentration of 128 p,g/ml. Co-trimoxazole (1:20 trimethoprim/sulfamethoxazole ratio) at a concentration of 6.25 p,ug/ml or less inhibited 98.9o of all strains, and the strain not inhibited by this concentration was effectively inhibited when the concentration was increased to 12. using a medium different from that of other investigators. Hall and Manion (7) found that in 27 Brucella strains studied, among which figured the six known species, the MIC of tetracycline is between 0.15 and 10 ,ug/ml. These researchers also found that 50% of the strains are inhibited by rifampin at concentrations of 0.3 to 1.25 ,ug/ ml. Farrell et al. (6) , in a study-involving 100 Brucella strains (including B. melitensis, B. abortus, and B. suis), found that the MIC of tetracycline is between 0.1 and 1.4 ,ug/ml. Corbel (3), in a study of 107 Brucella strains representing all species and biotypes of the genus, found that the MIC of rifampin is between 0.018 and 10 ,ug/ml. The findings of our study suggest that the MIC of tetracycline is between 0.1 and 0.5 ,.g/ml, and the MIC of rifampin is between 0.06 and 1 ,ug/ml. In regard to co-trimoxazole, Bushby (2) , in a study of 160 strains of B. abortus isolated from human and animal sources, found that 3.15 ,ug/ml inhibits 158 of the strains tested, and the 2 strains not inhibited by this concentration are effectively inhibited by a concentration of 10.5 ,ig/ml. In our study, the MIC of co-trimoxazole was between 0.39 to 6.25 ,ug/ml, although one strain required a concentration of 12.5 ,ug/ml to be inhibited. This shows that the in vitro susceptibility of B. melitensis to co-trimoxazole is quite similar to that of B. abortus. The results obtained for older cephalosporins are very poor. In their study, Hall and Manion were obliged to use concentrations of 12.5 to 25 jig/ml to inhibit just 50o of the strains, and they obtained total inhibition only at a concentration of 100 ,ug/ml or more (7) . Our results for cefoxitin show a similar pattern: we observed inhibition of only 15.3% of the strains at concentrations of 8 to 16 ,u.g/ml, and a concentration of 128 ,ug/ml was required to inhibit all strains. By contrast, we found N-F-thienamycin, a related compound that has already been reported by various investigators to be very active in vitro against gram-positive and gramnegative organisms (including anaerobes), to be effective against B. melitensis, which was inhibited by MICs between 0.1 and 2 ,ug/ml. It will, however, be necessary to perform more studies to determine the role of this new drug in the treatment of brucellosis.
We found that Iso-Sensitest Agar CM47L was satisfactory for growing Brucella spp.: it favored growth, enabled reproducible results to be obtained, and, because of its scanty thymidine content, did not require the addition of laked horse blood when co-trimoxazole was studied.
